Molecular Infectious Disease Testing Market to Hit USD 17.78 Billion by 2029 with 13.7% CAGR | MarketsandMarkets™.
The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust ...
unige.ch14d
A molecular syringe paves the way to new therapeutic approaches
A team from UNIGE, the Max Planck Institute for Molecular Physiology in Dortmund, and Heinrich Heine University in Düsseldorf has identified the attack mechanism of the Tc toxin produced by certain ...
Frontiers16d
Recent advances in molecular mechanisms of skin wound healing and its treatments
Wound healing is a complex process that involves several cellular and molecular systems, hence necessitating the use of multiple treatments rather than relying on a single approach. In order to ...
Phys.org22d
Scientists create 'molecular trap' to remove pollutants from water
These pollutants often find their way into water systems, where they disrupt ecosystems and cause harm to plants, animals and humans. While MOCs have been studied before for gas and chemical ...
C&EN22d
Modulation of Protein–Protein Interactions with Molecular Glues in a Synthetic Condensate Platform
Thijs W. van Veldhuisen - Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, P.O. Box 513, 5600 MB ...
BBC26d
Body found in search for missing man
Thomas Roche had five children and his family said he had had a head injury days before he went missing A body has been found as police search for a man who has been missing for more than three ...
Yahoo Finance26d
Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care
Basel, 22 January 2025 - Roche (SIX: RO, ROG ... with commercialisation under CE mark expected to follow shortly. “Rapid molecular point-of-care testing can revolutionise the clinical management ...
PharmiWeb28d
Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care
said Matt Sause, CEO Roche Diagnostics. The cobas liat system utilises gold-standard PCR technology to provide results in 20 minutes or less. The cobas liat assays are CLIA waived*, enabling ...